Furthermore, miR-21 plays an oncogenic role by targeting FOXO1 [451,452,453] and PTEN [454,455,456], thereby activating the PI3K/AKT/mTORC1 pathway in DLBCL [350]. This evidence concerns the gene FOXO1 and diffuse large B-cell lymphoma.